Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine in advanced or metastatic NSCLC
NCT01379976Phase 3Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Apr 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetyl-l-carnitine in non-small cell lung cancer (NSCLC), sponsored by Mario Negri Institute for Pharmacological Research. Started Apr 2011; status: terminated.
02
Drugs
acetyl-l-carnitine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01379976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379976.